Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

CRIA Update
Table of Contents, Fall 1998

About this Issue

This issue of CRIA Update is devoted to current controversies in HIV treatment. Dr. Carl Fichtenbaum of Washington University has contributed a timely, state-of-the-art review of the issues of stopping prophylaxis and treatment of opportunistic infections in persons on highly active antiretroviral therapy. Tim Horn, a regular contributing writer, has summarized some of the controversies surrounding drug failure and salvage therapy. In a separate article, Tim addresses the current thinking on immune reconstitution and immune-based therapies. Jill Cadman updates us on the new issues surrounding perinatal transmission of HIV, and the controversial topic of post-exposure prophylaxis is detailed in a balanced article by Mike Barr. To start, CRIA's Medical Director highlights some of the key issues surrounding strategies of antiretroviral therapy.

FORUM UPDATE

CRIA co-sponsors monthly educational forums on AIDS research and treatment issues. Upcoming forums:

Wednesday, October 14th
New Drugs in Development

Advertisement
Wednesday, November 11th
The Immune System and Long-Term Survival

Wednesday, December 9th
Pediatric / Adolescent Update

The forums are held at 7PM in the Cronin Auditorium, 10th Floor of St. Vincent's Hospital at 11th Street and 7th Avenue, Manhattan.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS Community Research Initiative of America. It is a part of the publication CRIA Update. Visit ACRIA's website to find out more about their activities, publications and services.
 

Tools
 

Advertisement